Report for Q3 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600511)"China National Medicines Corporation Ltd."Report for Q3 2026
Filed with SSE · Stock code 600511 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)China National Medicines Corporation Ltd. on 6ix
Earlier from China National Medicines
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
- Announcement on Resolutions of the 41st Meeting of the 8th Board of Directors
- Announcement on Opening of a Special Account for Temporarily Supplementing Working Capital with Raised Funds and Signing of a Regulatory Agreement
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
Follow China National Medicines into a list and get an email when it puts out news.
Follow China National Medicines